Commercial Hybrid Work Models: Workforce Engagement & Impact

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Improving Hybrid Work Models in Commercial Biopharma Organizations: Driving Workforce Engagement and Strategic Impact”

STUDY OVERVIEW

As hybrid work becomes permanent, commercial biopharma organizations face growing challenges in sustaining culture, engagement, and performance across increasingly dispersed teams. Beyond structural design, success now hinges on how effectively leaders manage talent, prevent burnout, and deploy technology to support collaboration at scale.

This study explores how leading organizations address cultural and technology barriers, implement workforce engagement strategies, and track hybrid effectiveness through meaningful KPIs. It highlights lessons learned in onboarding, leadership visibility, and employee well-being, while uncovering best practices in technology standardization and omnichannel customer engagement. The research also offers a forward-looking perspective on workplace flexibility—helping senior leaders future-proof hybrid strategies and convert organizational risk into long-term strategic advantage.

KEY TOPICS

Barriers to Hybrid and Remote Work
Employee Engagement and Technology Lessons
KPIs for Measuring Hybrid Impact
Future Outlook for Workplace Flexibility
Customer Engagement Patterns in Hybrid Models

KEY METRICS

Turnover rates for field and leadership roles in hybrid environments
Factors influencing hybrid adoption at commercial biopharma organizations
Skills prioritized for remote-ready hiring
KPIs for measuring hybrid impact across commercial functions
Breakdown of channels facilitating sales rep interactions
Average number of remote and in-person KOL interactions per month
Measuring value of interactions across different engagement formats
Facility adaptations for hybrid work
Benefits of remote / hybrid work environments
Barriers to hybrid adoption at commercial biopharma organizations
Future perspectives on hybrid work
Factors influencing the current size and composition of field roles

SAMPLE KEY FINDINGS

Turnover Risk in Field Roles: Field sales experience the highest attrition under hybrid models, signaling need for tailored policies.

Barriers to Hybrid and Remote Work: The most significant challenges to hybrid work remain tied to social connection and cultural integration. Remote employees report missing informal interactions and creative exchanges that typically occur in-office.

METHODOLOGY

Best Practices, LLC conducted benchmarking with 9 commercial leaders from 8 biopharma companies, supplemented by interviews to capture deeper insights on workforce engagement and strategic enablement.

Industries Profiled:
Pharmaceutical; Biotech; Health Care; Biopharmaceutical; Clinical Research; Laboratories

Companies Profiled:
Bial; Boehringer Ingelheim; Gr�nenthal; Paratek Pharmaceuticals; Pfizer; Sanofi; Takeda; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Improving Hybrid Work Models in Commercial Biopharma Organizations: Driving Workforce Engagement and Strategic Impact

ID: 5905

Features:

Pages/Slides: 28

Published: 2025

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B49324816DBAF86300258D61003A49AF
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-commercial-hybrid-work-models-workforce-engagement-strategic-impact?opendocument
18
19opendocument
2018.97.9.169
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB